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The York Tissue Bank was established in 2013 at the University of York as a repository for cells and 
tissues to facilitate clinical and translational research at the university and with collaborative external 
tissue bank applicants. The bioresource described in this publication was initially established to conduct 
investigations into infection processes of sexually transmitted diseases in ex vivo organotypical  models, 
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(1) Bioresource Overview
Project description
York Tissue Bank (YTB) is hosted within the Centre for 
Immunology and Infection in the Department of Biology 
and Hull York Medical School of the University of York and 
is approved by the Health Research Authority (National 
Research Ethics Service) Leeds East Research Ethics 
Committee (ref: 15/YH/0016); our license number granted 
by the Human Tissue Authority under section 16 (2) (e) (ii) 
of the Human Tissue act 2004 is 12604. The tissue bank 
is funded by the University of York with a cost-recovery 
model implemented for applicants to the biobank.
UK National Research Ethics Service (NRES 11/YH/0321) 
and Research & Development at York Teaching Hospital 
NHS foundation Trust (YORA01992) ethically approved 
a study entitled ex vivo cervical implant systems for the 
analysis of viral infections and transmission blockade with 
the University of York as sponsor. Tissue was initially 
collected to meet the requirements of this study but 
latterly, following amendment (substantial amendment 
2  17/9/15) to the ethically approved protocol and 
re-consent of patients, where possible, specifically for the 
tissue bank and henceforth available for suitable tissue 
bank applicants to access.
&ODVVL1謀cDWLRQ
Human.
Species
Human.
&ODVVL1謀cDWLRQ
Biological samples.
Context
Spatial coverage
Description: samples were collected at York Teaching 
Hospital NHS Foundation Trust, The York Hospital, 
Wigginton Road York, UK, YO31 8HE.
Latitude: 53.971
Longitude: 1.08
Temporal coverage
Collection period was between 23rd March 2012 and 
19th June 2014.
Temporal coverage for accessibility
No end date is applicable.
0HWKRGV
Steps
Written informed consent using York Tissue Bank patient 
information sheets and consent forms was obtained from 
women willing to donate uterine cervical tissue who had nor-
mal cervical smears and were undergoing a planned hysterec-
tomy for their own health. After hysterectomy the uterus was 
transported to the York Teaching Hospital NHS Foundation 
Trust histopathology department and reviewed macroscopi-
cally by the consultant histopathologist. Approximately 90% 
of normal, healthy, cervix was released and transported to the 
university for codification, processing and storage [1].
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Stabilization/preservation
Released cervical tissue was transferred into leakproof 
sterile sample pots containing a transportation medium 
(Leibovitzs L-15 medium containing heat-inactivated sin-
gle-batch 10% foetal bovine serum (FBS), 100 U/ml penicil-
lin, 100 Pg/ml streptomycin, and 2.5 Pg/ml amphotericin 
B [all from Invitrogen, Paisley, UK]) and cooled to 4°C 
for transportation to the University of York. All samples 
subsequently underwent processing within four hours of 
surgery. Endo- and ecto-cervix were separated visually and 
tissue was cut into approximately 1 cm3 cervical explant 
samples containing mucosal and submucosal tissue to 
maintain tissue architecture [2].
Type of long-term preservation
Cervical explant samples (a1 cm3) were placed individually 
into 2 ml cryovials on ice containing 1 ml of a pre-cooled 
(4°C) freezing medium (90% FBS with 10% dimethyl 
sulfoxide) sufficient to ensure cryoprotectant reached all 
the tissue. Cryovials were then transferred immediately 
to a control rate freezer pre-cooled to 4°C (Planer 
KRYO560-16, Planer PLC, Sunbury-on-Thames, UK) and 
H[SODQWVZHUHFRROHGIURP&WRÛ&DW&PLQDQG
WKHQIURPÛ&WRÛ&DW&PLQEHIRUHWUDQVIHUWR
liquid nitrogen for tissue banking [2].
Storage temperature
Liquid nitrogen: 196°C.
6KLSSLQJ WHPSHUDWXUH IURP SDWLHQWVRXUFH WR
SUHVHUYDWLRQRUUHVHDUFKXVH
04°C (on ice).
6KLSSLQJWHPSHUDWXUHIURPVWRUDJHWRUHVHDUFKXVH
78°C (on dry ice).
Quality assurance measures
1. Cervical tissue was recovered and processed within 
four hours of surgery.
2. Reagents used in the transport and freezing were pre-
pared freshly and were within their expiration date.
3. Freezer chamber temperature data was recorded as 
evidence of successful cycle completion; samples 
were transferred to liquid nitrogen immediately 
after controlled freezing.
4. Liquid nitrogen levels are monitored and refilled by 
centre staff; spare liquid nitrogen is always available 
at the university.
5. Access to liquid nitrogen tanks is restricted to  centre 
staff/students working on clinical research projects.
6. Liquid nitrogen tanks are stored in a purpose-built 
environmentally regulated room with oxygen level 
detectors and a constant supply of electricity with a 
backup generator in case of power outage.
7. Liquid nitrogen tank temperatures are constantly moni-
tored and logged; tanks are connected to an alarm system 
(mains operated and with a battery backup) that notifies 
centre staff if logged temperatures reach >160°C or 
<200°C for 30 minutes. Centre staff respond to call-
outs within 30 minutes to investigate cause of alarm.
8. YTB has an internal standard operating procedure 
in place for quality management of samples and 
storage in addition to regular internal audits.
Source of associated data
The tissue was designated to be normal on histological 
examination; donor date of birth is available.
(WKLFV6WDWHPHQW
UK National Research Ethics Service (NRES 11/YH/0321) 
and Research & Development at York Teaching Hospital 
NHS foundation Trust (YORA01992) ethically approved 
the original study entitled ex vivo cervical implant sys-
tems for the analysis of viral infections and transmis-
sion blockade, with University of York acting as the 
study sponsor. An amendment was latterly submitted 
to the Health Research authority ethics committee who 
approved the collection of cervical tissue for storage for 
future use under the universities HTA license within the 
York Tissue Bank; some patient samples collected prior 
to the amendment were re-consented, where possible. 
Written informed consent was obtained from women 
with normal cervical smears who needed to undergo a 
planned  hysterectomy for their own health and who were 
willing to donate cervical tissue.
Constraints
N/A
(3) Bioresource description
Object name
Cervical tissue explant.
Bioresource name
York Tissue Bank.
Bioresource location
York Tissue Bank, Centre for Immunology and Infection, 
Department of Biology and Hull York Medical School, 
Wentworth Way, University of York, York, YO10 5DD, UK.
Bioresource contact
biol622@york.ac.uk
+44 (0)1904 32 8867
Bioresource URL
https://www.york.ac.uk/cii/clinicaltranslationalresearch/
york-tissue-bank/
,GHQWL1謀eUXVHG
N/A
Bioresource type
Cell and tissue biobank.
Type of sampling
Population.
Anatomical site
Cervix.
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Disease status of patients/source
Healthy women.
&OLQLFDOFKDUDFWHULVWLFVRISDWLHQWVVRXUFH
Healthy women undergoing planned hysterectomy.
6L]HRIWKHELRUHVRXUFHb
The bioresource contains cervical tissue from 16 women: 
ectocervix is available from every donor with a total of 
195 samples available; endocervix is additionally available 
from two of 16 donors with four tissue samples available 
from each donor.
Donor  
number
Number of 
ectocervix 
samples
Number of 
endocervix 
samples
E0103 2 
E0105 10 
E0106 9 
E0111 9 
E0114 9 
E0117 1 
E0129 10 
E0135 15 4
E0137 18 
E0138 14 4
E0142 15 
E0144 15 
E0145 18 
E0147 15 
E0148 17 
E0151 18 
Vital state of patients/source
Healthy women.
Clinical diagnosis of patients/source
Healthy women undergoing planned hysterectomy.
3DWKRORJ\GLDJQRVLV
N/A
Control samples
N/A
Biospecimen type
Cervical tissue: approximately 1 cm3 tissue samples.
6L]HRIWKHELRUHVRXUFH
The bioresource described includes cervical tissue from 
16 women.
Release date
N/A
Access criteria
Application process is by request form completion accessi-
ble from the York Tissue Bank webpage with submission to 
the tissue bank manager who will pre-screen the applica-
tion form for appropriate justification of use prior to review 
by the York tissue bank management group (YTBMG). Our 
SOP060, available from the tissue bank manager, details 
the process and paperwork required. All human sample 
transfers out of the university are under the auspices of 
a Material Transfer Agreement and only to a recipient 
that has appropriate ethical approval from a recognised 
research ethics committee or they are operating under a 
valid and appropriate HTA license, as evidenced by submis-
sion of a copy of their approvals/licenses or approval from 
the designated individual at the recipient institute. We 
require completion of a risk assessment for the handling 
and transportation of the sample(s) to the recipient. 16 
donor samples are available, consisting of 203 1 cm3 cervi-
cal explant samples. Costs are required to cover expenses 
associated with shipment to the applicant. Access is 
restricted to research applications from qualified profes-
sionals that have been ethically approved by the appli-
cants local research ethics committee. Applicants must 
guarantee to acknowledge the York Tissue Bank in any sci-
entific publication. Research at the University of York and 
its collaborative partners is governed by the universities 
research policies and codes of practice https://www.york.
ac.uk/staff/research/governance/research-policies/.
(4) Reuse potential
The cervical tissue could be used in any research project 
requiring normal primary human uterine cervical tissue; 
samples were originally obtained to establish an ex vivo 
organo-typical model to conduct viral infection studies 
of sexually transmitted diseases, as has previously been 
described for HIV infection studies [3]. Cryopreserved 
cervical tissue has been demonstrated to remain viable 
with preserved tissue architecture after thawing [2, 4, 5] 
and retain the ability to be infected [4]. The 1 cm3 cervical 
explant samples available can be further processed (dis-
sected into smaller pieces, section etc.) into viable appro-
priate sized pieces for the respective applicant so each 
cervical explant sample has the potential for multiple 
experiments or replicates.
Acknowledgements
We acknowledge Fabiola Martin, previously of University 
of York, who led on cervical tissue sourcing; Alison 
Andrew, consultant histopathologist, Bill Hunter, con-
sultant gynaecologist and Christine Brewer, all from 
York Teaching Hospital, NHS Foundation Trust, York, 
UK, for releasing tissue and for donor recruitment and 
patient consent, respectively. We acknowledge Steven 
Pollock, Dawn Cartwright and Pat Coulson, all for-
merly of University of York, who were instrumental in 
the establishment of the York Tissue Bank. We further 
acknowledge Michael Barber, Contracts and Sponsorship 
Manager at University of York, who is responsible for 
material transfer agreements for sample transfer in/out 
of the YTB.
Fox et al: Bioresource of Cervical Tissue Explants from Healthy Women$UWۃSDJHۃRI
Competing Interests
The authors have no competing interests to declare.
$XWKRU5ROHV
James Fox: collector of Samples, York Tissue Bank Manager 
and York Tissue bank person designate.
Rebecca Wiggins: collector of Samples, ethical approval 
and York Tissue Bank person designate.
Charles Lacey: York Tissue Bank designated individual.
References
1. Fox, JM, Wiggins, RC, Moore, JWJ, Brewer, C, 
Hunter, B, Andrew, AC, et al. 2017. Corrigendum 
to Methodology for reliable and reproducible 
cryopreservation of human cervical tissue [Cryobiology 
77 (August 2017) 1418]. Cryobiology, 79: 87. DOI: 
https://doi.org/10.1016/j.cryobiol.2017.08.005
2. Fox, JM, Wiggins, RC, Moore, JWJ, Brewer, C, 
Andrew, AC and Martin, F. 2017. Methodology for 
reliable and reproducible cryopreservation of human 
cervical tissue. Cryobiology, 77: 148. DOI: https://doi.
org/10.1016/j.cryobiol.2017.06.004
3. Cummins, JE, Jr., Guarner, J, Flowers, L, 
Guenthner, PC, Bartlett, J, Morken, T, et al. 2007. 
Preclinical testing of candidate topical microbicides 
for anti-human immunodeficiency virus type 1 activity 
and tissue toxicity in a human cervical explant culture. 
Antimicrob Agents Chemother, 51(5): 17709. DOI: 
https://doi.org/10.1128/AAC.01129-06
4. Gupta, P, Ratner, D, Patterson, BK, Kulka, K, Rohan, 
LC, Parniak, MA, et al. 2006. Use of frozen-thawed 
cervical tissues in the organ culture system to measure 
anti-HIV activities of candidate microbicides. AIDS Res 
Hum Retroviruses, 22(5): 41924. DOI: https://doi.
org/10.1089/aid.2006.22.419
5. Sassi, AB, McCullough, KD, Cost, MR, Hillier, SL 
and Rohan, LC. 2004. Permeability of tritiated water 
through human cervical and vaginal tissue. J Pharm 
Sci, 93(8): 200916. DOI: https://doi.org/10.1002/
jps.20107
+RZWRFLWHWKLVDUWLFOH Fox, JM, Wiggins, RC and Lacey, CJ. 2018. Bioresource of Cervical Tissue Explants from Healthy 
Women. Open Journal of Bioresources, 5: 11. DOI: https://doi.org/10.5334/ojb.49
3XEOLVKHG18 September 2018
&RS\ULJKW © 2018 The Author(s). This is an open-access article distributed under the terms of the Creative Commons 
Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
Open Journal of Bioresources is a peer-reviewed open access journal published by Ubiquity Press OPEN ACCESS
